|
End-of-day quote
Shanghai S.E.
17/08/2026
|
5-day change | 1st Jan Change | ||
| 3.930 CNY | +1.29% |
|
+4.80% | -1.26% |
| Market Cap | 308.27Cr 46Cr 39Cr 37Cr 34Cr 63Cr 4.37TCr 64Cr 434.17Cr 170.14Cr 2.19TCr 171.69Cr 167.97Cr 7.29TCr | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 329.98Cr 49Cr 42Cr 40Cr 36Cr 68Cr 4.68TCr 69Cr 464.75Cr 182.12Cr 2.34TCr 183.78Cr 179.8Cr 7.8TCr | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
68.56% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.29% | ||
| 1 week | +4.80% | ||
| Current month | +10.39% | ||
| 1 month | +8.86% | ||
| 3 months | +0.26% | ||
| 6 months | -2.00% | ||
| Current year | -1.26% |
| 1 week | 3.7 | 4.1 | |
| 1 month | 3.15 | 4.1 | |
| Current year | 2.85 | 5.27 | |
| 1 year | 2.85 | 5.27 | |
| 3 years | 2.76 | 6.15 | |
| 5 years | 2.76 | 8.8 | |
| 10 years | 2.76 | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 13/05/2021 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 06/09/2024 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 17/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 22/01/2009 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 21/02/2011 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 03/01/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.29% | +4.80% | -5.98% | -28.02% | 45Cr | ||
| +0.28% | -3.73% | +69.90% | +120.59% | 1,05200Cr | ||
| +0.93% | +0.24% | +48.90% | +50.82% | 63TCr | ||
| +0.32% | +0.95% | +21.18% | +66.86% | 44TCr | ||
| +0.28% | -3.05% | +39.10% | +36.65% | 35TCr | ||
| +0.78% | -2.05% | +24.03% | +36.97% | 29TCr | ||
| +0.87% | -3.59% | -1.52% | +7.12% | 24TCr | ||
| +0.58% | +0.19% | +42.85% | +58.43% | 22TCr | ||
| -0.78% | -4.49% | -15.86% | -54.13% | 20TCr | ||
| -0.29% | +4.43% | +17.77% | +81.65% | 17TCr | ||
| Average | +0.31% | -0.43% | +24.04% | +37.69% | 35.96TCr | |
| Weighted average by Cap. | +0.30% | -0.63% | +39.83% | +63.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 217.4Cr 32Cr 28Cr 26Cr 24Cr 45Cr 3.08TCr 45Cr 306.2Cr 119.99Cr 1.54TCr 121.08Cr 118.46Cr 5.14TCr | 186.29Cr 28Cr 24Cr 22Cr 20Cr 38Cr 2.64TCr 39Cr 262.38Cr 102.82Cr 1.32TCr 103.75Cr 101.51Cr 4.4TCr |
| Net income | -32Cr -4.71Cr -4.06Cr -3.81Cr -3.47Cr -6.53Cr -449.93Cr -6.62Cr -45Cr -18Cr -225.41Cr -18Cr -17Cr -749.82Cr | -33Cr -4.89Cr -4.22Cr -3.96Cr -3.61Cr -6.78Cr -467.44Cr -6.88Cr -46Cr -18Cr -234.19Cr -18Cr -18Cr -779.01Cr |
| Net Debt | 41Cr 6.1Cr 5.26Cr 4.94Cr 4.5Cr 8.45Cr 582.78Cr 8.57Cr 58Cr 23Cr 291.97Cr 23Cr 22Cr 971.23Cr | 22Cr 3.22Cr 2.78Cr 2.61Cr 2.38Cr 4.47Cr 307.94Cr 4.53Cr 31Cr 12Cr 154.28Cr 12Cr 12Cr 513.2Cr |
Employees
4,832
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | CN¥3.930 | +1.29% | 3,60,16,200 |
| 14/26/14 | CN¥3.880 | -1.02% | 3,16,61,635 |
| 13/26/13 | CN¥3.920 | +1.03% | 5,39,38,879 |
| 12/26/12 | CN¥3.880 | +1.31% | 4,17,02,400 |
| 11/26/11 | CN¥3.830 | +1.32% | 5,27,95,126 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
















